Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study

Table 1

Patient characteristics.

	All	Allergic asthma	Nonallergic asthma	Control	value
Subjects,	137	53	29	55	—
Gender (M/F)	47/90	22/31	12/17	13/42	0.1
Age, years, mean (SD)	37.93 (19.38)	37.42 (22.25)	34.17 (22.2)	40.42 (14.12)	0.47
Smoking (yes/no)	26/137	8/45	3/26	15/40	0.11
Current use of inhaled or oral corticosteroid^# (%)	23 (16.7)	16 (30.2)	7 (25.1)	0 (0)	<0.001

^#As reported by patients at the time of assessment. Significantly lower.